SCHEMBL6408652

SCHEMBL6408652

Cc1c(-c2ccc(Cl)cc2)oc2ncnc(Oc3cccc(O)c3)c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 1/20 0.43
BRAF P15056 1/20 0.43
EGFR P00533 1/20 0.43
RET P07949 1/20 0.42
KIF5B P33176 1/20 0.42
KDR P35968 1/20 0.42
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
HPGD P15428 2/20 0.41
HTT P42858 2/20 0.40
EIF2AK2 P19525 1/20 0.38
GSK3B P49841 1/20 0.38
MRGPRX1 Q96LB2 2/20 0.38
RAB9A P51151 1/20 0.38
TEK Q02763 1/20 0.38
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
MAPT P10636 1/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6410890 0.88 CFTR (0.45) EGFRKDRMEN1KMT2AHPGD
SCHEMBL6410337 0.72 ALDH1A1 (0.44) EGFRKDRMEN1KMT2AHPGD
SCHEMBL6408208 0.70 ALDH1A1 (0.43) EGFRKDRMEN1KMT2AHPGD
SCHEMBL6412162 0.66 TEK (0.56) KDRMEN1KMT2AHPGDGSK3B
SCHEMBL30628468 0.64 TSHR (0.50) MEN1KMT2AHPGDRAB9AMAPT
SCHEMBL1277058 0.64 TSHR (0.50) MEN1KMT2AHPGDRAB9AMAPT
SCHEMBL15077970 0.64 RAF1 (0.80) RAF1BRAFEGFRRETKIF5B
SCHEMBL6433669 0.64 CFTR (0.43) EGFRMEN1KMT2AKDM4ETHRB
SCHEMBL6432626 0.62 EGFR (0.42) EGFRKDRGSK3BRAB9A
SCHEMBL6408590 0.62 TEK (0.41) EGFRKDRMEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005092896-A1 COMPOUND FOR INHIBITING TYROSINE KINASE ACTIVITY OF DDR2 PROTEIN KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2005-10-06 WO disclosed